Effects of ertugliflozin on uric acid and gout-related outcomes: post hoc analyses from VERTIS CV

被引：0
|
作者：
Sridhar, V. S. [1 ,2 ]
Cosentino, F. [3 ,4 ]
Dagogo-Jack, S. [5 ]
Pratley, R. [6 ]
Frederich, R. [7 ]
Essex, M. Noyes [8 ]
Maldonado, M. [9 ]
Liu, C. -C. [10 ]
Mancuso, J. P. [11 ]
Cherney, D. Z. I. [1 ,2 ]
机构：
[1] Univ Hlth Network, Div Nephrol, Dept Med, Toronto, ON, Canada
[2] Univ Toronto, Toronto, ON, Canada
[3] Karolinska Inst, Unit Cardiol, Stockholm, Sweden
[4] Karolinska Univ Hosp, Stockholm, Sweden
[5] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA
[6] AdventHlth Translat Res Inst, Orlando, FL USA
[7] Pfizer Inc, Collegeville, PA USA
[8] Pfizer Inc, New York, NY USA
[9] MSD Ltd, London, England
[10] Merck & Co Inc, Kenilworth, NJ USA
[11] Pfizer Inc, Groton, CT 06340 USA
来源：
DIABETOLOGIA | 2022年 / 65卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
621
引用
收藏
页码：S318 / S319
页数：2
相关论文
共 50 条
  • [31] Cardiorenal outcomes by indices of liver steatosis and fibrosis in individuals with type 2 diabetes and atherosclerotic cardiovascular disease: Analyses from VERTIS CV, a randomized trial of the sodium-glucose cotransporter-2 inhibitor ertugliflozin
    Corbin, Karen D.
    Dagogo-Jack, Samuel
    Cannon, Christopher P.
    Cherney, David Z. I.
    Cosentino, Francesco
    Frederich, Robert
    Liu, Jie
    Pong, Annpey
    Lin, Jianxin
    Cater, Nilo B.
    Pratley, Richard E.
    [J]. DIABETES OBESITY & METABOLISM, 2023, 25 (03): : 758 - 766
  • [32] Effect of fenofibrate on uric acid and gout in type 2 diabetes: a post-hoc analysis of the randomised, controlled FIELD study
    Waldman, Boris
    Ansquer, Jean-Claude
    Sullivan, David R.
    Jenkins, Alicia J.
    McGill, Neil
    Buizen, Luke
    Davis, Timothy M. E.
    Best, James D.
    Li, Liping
    Feher, Michael D.
    Foucher, Christelle
    Kesaniemi, Y. Antero
    Flack, Jeffrey
    d'Emden, Michael C.
    Scott, Russell S.
    Hedley, John
    Gebski, Val
    Keech, Anthony C.
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (04): : 310 - 318
  • [33] Effect of bempedoic acid on uric acid and gout in 3621 patients with hypercholesterolemia: pooled analyses from phase 3 trials
    Ray, K. K.
    Bakris, G. L.
    Banach, M.
    Catapano, A.
    Duel, P. B.
    Mancini, G. B. J.
    Bloedon, L.
    Feng, A.
    Gotto, A. M., Jr.
    [J]. EUROPEAN HEART JOURNAL, 2020, 41 : 3001 - 3001
  • [34] EFFECT OF SERUM URIC ACID (SUA) ON GOUT FLARES (GF) AND TOPHI RESOLUTION IN GOUT PATIENTS. POOLED POST HOC ANALYSIS OF CLEAR 1 & CLEAR 2 TRIALS
    Perez-Ruiz, F.
    Richette, P.
    Karra, R. G.
    Wild, I.
    Hagedorn, H.
    Kandaswamy, P.
    Bardin, T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 658 - 659
  • [35] Should Cardiologists Risk-stratify Patients With Atherosclerotic Cardiovascular Disease by Kidney Function? Results From the VERTIS CV Trial Evaluating Efficacy of Ertugliflozin on Cardiovascular and Kidney Outcomes by Baseline Kidney Function
    Cherney, David
    Charbonnel, Bernard
    Cosentino, Francesco
    Pratley, Richard
    Dagogo-Jack, Samuel
    Shih, Weichung J.
    McGuire, Darren K.
    Frederich, Robert
    Maldonado, Mario
    Liu, Jie
    Pong, Annpey
    Liu, Chih-Chin
    Cannon, Christopher P.
    [J]. CIRCULATION, 2020, 142 (24) : E483 - E483
  • [36] Effects of empagliflozin on uric acid levels and gout: observations from the EMPA-REG OUTCOME trial
    Ferreira, Joao P.
    Inzucchi, Silvio E.
    Zinman, Bernard
    Mattheus, Michaela
    Meinicke, Thomas
    Steubl, Dominik
    Wanner, Christoph
    [J]. INTERNIST, 2022, 63 (SUPPL 3): : 317 - 318
  • [37] Effects of empagliflozin on uric acid levels and gout: observations from the EMPA-REG OUTCOME trial
    Ferreira, J. P.
    Inzucchi, S. E.
    Zinman, B.
    Mattheus, M.
    Meinicke, T.
    Steubl, D.
    Wanner, C.
    [J]. DIABETOLOGIA, 2021, 64 (SUPPL 1) : 31 - 32
  • [38] Dose-related beneficial and harmful effects of gabapentin in postoperative pain management - post hoc analyses from a systematic review with meta-analyses and trial sequential analyses
    Fabritius, Maria Louise
    Wetterslev, Jorn
    Mathiesen, Ole
    Dahl, Jorgen B.
    [J]. JOURNAL OF PAIN RESEARCH, 2017, 10 : 2547 - 2563
  • [39] Improvements in Fatigue Correlate with Changes in Clinical and Hematological Outcomes: Post Hoc Analyses from the Pegasus Study
    Cella, David
    Lenderking, William R.
    Sarda, Sujata P.
    Baver, Scott B.
    Hamdani, Mohamed
    Hsieh, Ray
    Shaffer, Shannon
    Roth, Alexander
    [J]. BLOOD, 2020, 136
  • [40] Uric acid predicts adverse outcomes in chronic kidney disease: a novel insight from trajectory analyses
    Tsai, Ching-Wei
    Chiu, Hsien-Tsai
    Huang, Han-Chun
    Ting, I-Wen
    Yeh, Hung-Chieh
    Kuo, Chin-Chi
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 (02) : 231 - 241
12345